Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial

被引：0

作者：

Carol A. Burke

Evelien Dekker

N. Jewel Samadder

Elena Stoffel

Alfred Cohen

机构：

[1] Cleveland Clinic,Department Gastroenterology & Hepatology

[2] Academic Medical Center,Department Gastroenterology & Hepatology

[3] C2-115,Division of Gastroenterology

[4] University of Utah,Comprehensive Cancer Center

[5] Huntsman Cancer Institute,undefined

[6] 2000 Circle of Hope,undefined

[7] University of Michigan Health System,undefined

[8] 1500 E. Medical Center Dr,undefined

[9] Cancer Prevention Pharmaceuticals,undefined

[10] Inc.,undefined

来源：

BMC Gastroenterology | / 16卷

关键词：

Chemoprevention; Colon polyps; Colorectal polyposis; Duodenal polyposis; Eflornithine; Familial adenomatous polyposis; Placebo controlled; Polyamines; Sulindac;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial
Burke, Carol A.
Dekker, Evelien
Samadder, N. Jewel
Stoffel, Elena
Cohen, Alfred
[J]. BMC GASTROENTEROLOGY, 2016, 16
[2] EFFICACY AND SAFETY OF COMBINED CPP-1X/SULINDAC VS CPP-1X OR SULINDAC ALONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS: RESULTS FROM A DOUBLE-BLIND, RANDOMIZED PHASE III TRIAL
Burke, Carol A.
Samadder, N. Jewel
Dekker, Evelien
Lim, Ramona M.
Balaguer, Francesc
Gallinger, Steven
Huneburg, Robert
Strassburg, Christian P.
Lynch, Patrick M.
Cohen, Alfred
Gupta, Samir
Stoffel, Elena M.
[J]. GASTROENTEROLOGY, 2019, 156 (06) : S79 - S79
[3] A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
Jeong, Han Saem
Hong, Soon Jun
Cho, Jin-Man
Han, Ki Hoon
Cha, Dong-Hun
Jo, Sang-Ho
Kang, Hyun-Jae
Choi, So-Yeon
Choi, Cheol Ung
Cho, Eun Jeong
Jeong, Young-Hoon
Gwon, Hyeon-Cheol
Kim, Byeong-Keuk
Lee, Sung Yun
Kim, Sang-Hyun
Ahn, Jeong Cheon
Hong, Young Joon
Kim, Woo-Shik
Woo, Seong-Ill
Park, Tae-Ho
Han, Kyoo-Rok
[J]. CLINICAL THERAPEUTICS, 2022, 44 (10) : 1310 - 1325
[4] Efficacy and Safety of Parecoxib/Phloroglucinol Combination Therapy Versus Parecoxib Monotherapy for Acute Renal Colic: A Randomized, Double-Blind Clinical Trial
Fu, Weihua
Yao, Jiwei
Li, Qianwei
Wang, Yongquan
Wu, Xiaojun
Zhou, Zhansong
Li, Wei-Bing
Yan, Jun-An
[J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 69 (01) : 157 - 161
[5] Efficacy and Safety of Parecoxib/Phloroglucinol Combination Therapy Versus Parecoxib Monotherapy for Acute Renal Colic: A Randomized, Double-Blind Clinical Trial
Weihua Fu
Jiwei Yao
Qianwei Li
Yongquan Wang
Xiaojun Wu
Zhansong Zhou
Wei-Bing Li
Jun-An Yan
[J]. Cell Biochemistry and Biophysics, 2014, 69 : 157 - 161
[6] Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and HypertriglyceridemiaA Randomized, Double-Blind Study
Eli M. Roth
James M. McKenney
Maureen T. Kelly
Carolyn M. Setze
Dawn M. Carlson
Alex Gold
James C. Stolzenbach
Laura A. Williams
Peter H. Jones
[J]. American Journal of Cardiovascular Drugs, 2010, 10 : 175 - 186
[7] Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia A Randomized, Double-Blind Study
Roth, Eli M.
McKenney, James M.
Kelly, Maureen T.
Setze, Carolyn M.
Carlson, Dawn M.
Gold, Alex
Stolzenbach, James C.
Williams, Laura A.
Jones, Peter H.
[J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (03) : 175 - 186
[8] A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
Kim, Kwang-il
Shin, Mi-Seung
Ihm, Sang-Hyun
Youn, Ho-Joong
Sung, Ki-Chul
Chae, Shung Chull
Nam, Chang-Wool
Seo, Hong Seog
Park, Seong-Mi
Rhee, Moo-Yong
Kim, Moo Hyun
Cha, Kwang Soo
Kim, Yong-Jin
Kim, Jae-Joong
Chun, Kook Jin
Yoo, Byung-Su
Park, Sungha
Shin, Eun-Seok
Kim, Dong-Soo
Kim, Doo Il
Kim, Kye Hun
Joo, Seung-Jae
Jeong, Jin-Ok
Shin, Jinho
Kim, Cheol Ho
[J]. CLINICAL THERAPEUTICS, 2016, 38 (10) : 2159 - 2170
[9] Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial
Lee, Chan Joo
Kang, Woong Chol
Ihm, Sang Hyun
Sohn, Il Suk
Woo, Jong Shin
Kim, Jin Won
Hong, Soon Jun
Choi, Jung Hyun
Suh, Jung-Won
Seo, Jae-Bin
Doh, Joon-Hyung
Son, Jung-Woo
Park, Jae-Hyeong
Lee, Ju-Hee
Hong, Young Joon
Heo, Jung Ho
Shin, Jinho
Kang, Seok-Min
[J]. JOURNAL OF CLINICAL HYPERTENSION, 2024, 26 (03): : 262 - 273
[10] Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study
Dogra, Sunil
Sumathy, T. K.
Nayak, Chitra
Ravichandran, G.
Vaidya, Pradyumna Prakash
Mehta, Suyog
Mittal, Rajan
Mane, Amey
Charugulla, Sujeet Narayan
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (08) : 925 - 933

← 1 2 3 4 5 →